John Forbes Selected Research

John Forbes Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 07/2021 - 04/2004
8	Stroke (Strokes) 03/2024 - 09/2016
5	Neoplasms (Cancer) 03/2015 - 03/2008
3	Infections 09/2006 - 05/2003
2	Coronary Disease (Coronary Heart Disease) 06/2021 - 04/2016
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 01/2018
2	Angina Pectoris 01/2018 - 01/2017
2	Ischemic Stroke 09/2016 - 06/2004
2	Anemia 09/2004 - 05/2003
1	Hyponatremia 04/2024
1	Aphasia (Dysphasia) 03/2024
1	Embolic Stroke 06/2021
1	Inflammation (Inflammations) 06/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Diabetes Mellitus 01/2021
1	Bone Fractures (Bone Fracture) 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Obesity 01/2020
1	Pain (Aches) 10/2019
1	Stable Angina 01/2018
1	Headache (Headaches) 10/2017
1	Nausea 10/2017
1	Vomiting 10/2017
1	Myocardial Infarction 04/2016
1	Hemorrhage 03/2012
1	Critical Illness (Critically Ill) 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 08/2006
1	Iron Deficiencies 09/2004
1	Hepatolenticular Degeneration (Wilson's Disease) 06/2004
1	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2003

Drug/Important Bio-Agent (IBA)

8	Tamoxifen FDA LinkGeneric 07/2021 - 08/2006
7	Anastrozole (Arimidex)FDA LinkGeneric 07/2021 - 09/2003
5	Fluoxetine (Prozac)FDA LinkGeneric 03/2024 - 12/2017
4	Hormones (Hormone)IBA 03/2015 - 08/2006
3	Estrogen ReceptorsIBA 07/2011 - 03/2008
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2016 - 06/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2010 - 03/2008
2	Aromatase InhibitorsIBA 01/2010 - 08/2006
2	Proteins (Proteins, Gene)FDA Link 09/2006 - 06/2004
2	IronIBA 09/2004 - 05/2003
1	InterleukinsIBA 06/2021
1	Colchicine FDA LinkGeneric 06/2021
1	Tubulin ModulatorsIBA 06/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	CholesterolIBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2020
1	SugarsIBA 01/2020
1	theasinensin AIBA 01/2020
1	Troponin IIBA 01/2018
1	TroponinIBA 01/2018
1	Peptides (Polypeptides)IBA 03/2015
1	AnionsIBA 03/2015
1	LigandsIBA 03/2015
1	Sulfates (Sulfates, Inorganic)IBA 03/2015
1	Sulfobromophthalein (Sulfobromophthalein Sodium)IBA 03/2015
1	RadiopharmaceuticalsIBA 03/2015
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2013
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013
1	Fluorouracil (Carac)FDA LinkGeneric 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	Prednisone (Sone)FDA LinkGeneric 01/2013
1	Trastuzumab (Herceptin)FDA Link 01/2011
1	Carboplatin (JM8)FDA LinkGeneric 01/2011
1	Docetaxel (Taxotere)FDA Link 01/2011
1	RNA (Ribonucleic Acid)IBA 04/2010
1	Formaldehyde (Formol)FDA Link 03/2008
1	ParaffinIBA 03/2008
1	Epidermal Growth Factor (EGF)IBA 03/2008
1	Virulence Factors (Pathogenicity Factors)IBA 09/2006
1	ProteomeIBA 09/2006
1	exemestane (Aromasin)FDA Link 08/2006
1	Pyruvate KinaseIBA 06/2005
1	CopperIBA 06/2004
1	Adenosine Triphosphatases (ATPase)IBA 06/2004
1	natural resistance-associated macrophage protein 1IBA 05/2003
1	MetalsIBA 05/2003

Therapy/Procedure

11	Therapeutics 07/2021 - 08/2006
2	Secondary Prevention 01/2024 - 06/2021
2	Drug Therapy (Chemotherapy) 01/2013 - 01/2011
1	Time-to-Treatment 03/2024
1	Compression Stockings 03/2012
1	Critical Care (Surgical Intensive Care) 01/2012
1	Thrombolytic Therapy 06/2004